Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate versus ketamine for rapid sequence intubation in adult multiple trauma patients
IRCT20171106037280N3Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ketamine and etomidate in polytrauma (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Death at emergency department or during hospital admission, Duration of survival during hospital admission and 3 more. Started Jan 2019; status: completed.
02
Drugs
ketamineetomidate
03
Conditions
polytrauma
Beyond the preview
Go deeper on IRCT20171106037280N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171106037280N3.